Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer: A Randomized Phase 2 PrECOG Study (PrE0501)

Autor: Aisner, Joseph, Manola, Judith B., Dakhil, Shaker R., Stella, Philip J., Sovak, Mika A., Schiller, Joan H.
Zdroj: In Journal of Thoracic Oncology August 2013 8(8):1075-1083
Databáze: ScienceDirect